Search results
3 lis 2020 · On October 5, 2020, the Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration (FDA) proposed withdrawal of approval of Makena (hydroxyprogesterone caproate...
This Medical News story examines the status of Makena, the only drug approved for the indication of preventing preterm birth.
Hydroxyprogesterone caproate is available alone in the form of ampoules and vials of 125 and 250 mg/mL oil solutions for intramuscular injection (brand names Proluton, Makena). [ 56 ] [ 57 ] It is also available alone in the form of a 250 mg/mL autoinjector for use by subcutaneous injection (brand name Makena).
25 mar 2022 · By Christina Jewett. March 25, 2022. By the time Brittany Bonds gave birth to her third son in the back of an ambulance 10 weeks before he was due, she no longer trusted the drug Makena. The drug...
7 mar 2023 · Preterm Birth Drug Withdrawn After 12 Years. The F.D.A. seemed poised to rescind approval of Makena, after studies over time indicated the treatment did not halt early childbirth for many women...
6 kwi 2023 · Following years of back-and-forth between the agency and the drugmaker Covis Pharma, the FDA's decision came suddenly Thursday. It means the medication, Makena, and its generics are no longer ...
24 sty 2020 · An expert panel convened by the FDA says the drug Makena should be withdrawn from the market because a review of its effectiveness shows it doesn't work. But OB-GYNS who prescribe the drug...
